Tyler Knight

903 total citations
29 papers, 571 citations indexed

About

Tyler Knight is a scholar working on Surgery, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Tyler Knight has authored 29 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pharmacology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Tyler Knight's work include Musculoskeletal pain and rehabilitation (6 papers), Spine and Intervertebral Disc Pathology (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Tyler Knight is often cited by papers focused on Musculoskeletal pain and rehabilitation (6 papers), Spine and Intervertebral Disc Pathology (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Tyler Knight collaborates with scholars based in United States, France and Switzerland. Tyler Knight's co-authors include Caroline Schaefer, Stacey J. Ackerman, Gergana Zlateva, Michael Y. Wang, Luella Engelhart, Matthew J. McGirt, Paul Park, Jason Lerner, Tim Holt and David W. Polly and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Investigative Ophthalmology & Visual Science.

In The Last Decade

Tyler Knight

29 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyler Knight United States 13 222 194 164 89 77 29 571
Stephanie Ensworth Canada 14 73 0.3× 132 0.7× 25 0.2× 104 1.2× 48 0.6× 23 836
Richard Menger United States 14 448 2.0× 280 1.4× 53 0.3× 26 0.3× 22 0.3× 75 800
Safinaz Ataoğlu Türkiye 11 66 0.3× 41 0.2× 80 0.5× 90 1.0× 18 0.2× 31 452
Rowena Ridout Canada 15 245 1.1× 156 0.8× 11 0.1× 12 0.1× 30 0.4× 23 836
Lauren M. Scarpati United States 8 76 0.3× 37 0.2× 27 0.2× 17 0.2× 17 0.2× 9 504
Wiley Chambers United States 13 44 0.2× 28 0.1× 14 0.1× 136 1.5× 69 0.9× 30 583
Alireza Firouzjahi Iran 12 51 0.2× 135 0.7× 39 0.2× 71 0.8× 5 0.1× 28 453
Miriam Kimel United States 14 15 0.1× 50 0.3× 27 0.2× 93 1.0× 68 0.9× 32 556
Robert L. Swezey United States 15 302 1.4× 137 0.7× 261 1.6× 66 0.7× 3 0.0× 49 687
V. Khullar United Kingdom 16 654 2.9× 53 0.3× 37 0.2× 40 0.4× 4 0.1× 30 1.6k

Countries citing papers authored by Tyler Knight

Since Specialization
Citations

This map shows the geographic impact of Tyler Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Knight more than expected).

Fields of papers citing papers by Tyler Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Knight. The network helps show where Tyler Knight may publish in the future.

Co-authorship network of co-authors of Tyler Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler Knight. A scholar is included among the top collaborators of Tyler Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler Knight. Tyler Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nesline, Mary, et al.. (2020). Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in US Clinical Practice. Clinical Therapeutics. 42(9). 1682–1698.e7. 29 indexed citations
2.
Ackerman, Stacey J., Tyler Knight, Peter Wahl, & Charles P. Cartwright. (2019). <p>Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population</p>. ClinicoEconomics and Outcomes Research. Volume 11. 179–189. 7 indexed citations
3.
Knight, Tyler, et al.. (2017). Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab. ClinicoEconomics and Outcomes Research. Volume 9. 271–279. 6 indexed citations
4.
Chatoth, Dinesh K., Peter Wahl, Viatcheslav Rakov, et al.. (2017). MP608REAL-WORLD OUTCOMES OF HYPERKALEMIA MANAGEMENT WITH PATIROMER IN END-STAGE RENAL DISEASE PATIENTS UNDERGOING HEMODIALYSIS IN THE UNITED STATES. Nephrology Dialysis Transplantation. 32(suppl_3). iii657–iii657. 3 indexed citations
5.
Anastassopoulos, Kathryn, Francis A. Farraye, Tyler Knight, et al.. (2016). A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study. Digestive Diseases and Sciences. 61(10). 2993–3006. 19 indexed citations
6.
Knight, Tyler, Caroline Schaefer, Holly B. Krasa, et al.. (2015). Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data. ClinicoEconomics and Outcomes Research. 7. 123–123. 21 indexed citations
7.
Knight, Tyler, et al.. (2015). Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States. Journal of Managed Care & Specialty Pharmacy. 21(10). 946–954. 17 indexed citations
8.
Ackerman, Stacey J., David W. Polly, Tim Holt, John Cummings, & Tyler Knight. (2014). Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population. ClinicoEconomics and Outcomes Research. 6. 63–63. 22 indexed citations
9.
10.
11.
Knight, Tyler, et al.. (2013). Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. ClinicoEconomics and Outcomes Research. 5. 171–171. 64 indexed citations
12.
Knight, Tyler, et al.. (2013). Burden Of Iron Deficiency Anemia In a Bariatric Surgery Population In The United States. Blood. 122(21). 1722–1722. 3 indexed citations
13.
Perrot, Serge, Caroline Schaefer, Tyler Knight, et al.. (2012). Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains. BMC Musculoskeletal Disorders. 13(1). 22–22. 28 indexed citations
14.
Knight, Tyler, et al.. (2012). Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). 40. 4751. 1 indexed citations
15.
Chertow, Glenn M., Zhanni Lu, Xiao Xu, et al.. (2011). Self‐reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low‐dose vitamin D sterols. Hemodialysis International. 16(2). 188–197. 23 indexed citations
16.
Knight, Tyler, et al.. (2010). Clinical and Economic Outcomes in Medicare Beneficiaries with Stage 3 or Stage 4 Chronic Kidney Disease and Anemia: The Role of Intravenous Iron Therapy. Journal of Managed Care Pharmacy. 16(8). 605–615. 10 indexed citations
17.
Brandenburg, Nancy A., Tyler Knight, Zdravko P. Vassilev, & R. Knight. (2009). Risk Factors for Venous Thromboembolism and the Use of Antithrombotic Prophylaxis in Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone Combination Regimens.. Blood. 114(22). 1385–1385. 1 indexed citations
18.
Cruess, Alan F., Gergana Zlateva, Xiao Xu, et al.. (2008). Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration. PharmacoEconomics. 26(1). 57–73. 90 indexed citations
19.
Buggage, Ronald, Xiao Xu, Alan F. Cruess, et al.. (2006). Clinical Characteristics and Impact of Neovascular Age–Related Macular Degeneration on Medical Status, Daily Living, Functioning, and Health Resource Utilization: A Survey of Five Countries. Investigative Ophthalmology & Visual Science. 47(13). 2208–2208. 2 indexed citations
20.
Ackerman, Stacey J., Tyler Knight, Jeff Schein, Chureen Carter, & Peter S. Staats. (2004). Risk of Constipation in Patients Prescribed Fentanyl Transdermal System or Oxycodone Hydrochloride Controlled-Release in a California Medicaid Population. The Consultant Pharmacist. 19(2). 118–132. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Ensworth Breakdown of academic impact, for papers by Richard Menger Breakdown of academic impact, for papers by Safinaz Ataoğlu Breakdown of academic impact, for papers by Rowena Ridout Breakdown of academic impact, for papers by Lauren M. Scarpati Breakdown of academic impact, for papers by Wiley Chambers Breakdown of academic impact, for papers by Alireza Firouzjahi Breakdown of academic impact, for papers by Miriam Kimel Breakdown of academic impact, for papers by Robert L. Swezey Breakdown of academic impact, for papers by V. Khullar
Rankless by CCL
2026